The automated, antideoxyribonuclease B (DNase B) immunoassay test for the diagnosis and management of streptococcal-based infections runs on the Immage immunoassay system. It quantitatively determines human antibodies to DNase B in serum samples.
A test for both skin and throat infections, the DNase B assay expands the Immage’s streptococcal test panel. In can increase sensitivity to streptococcal infections — acute rheumatic fever, acute glomerulonephritis, Sydenham’s chorea, scarlet fever, pharyngitis and other group A illnesses.
The DNase B assay, performed in conjunction with anti-streptolysin O (ASO) testing, detects strep infections with a high degree of reliability.
The test offers a measurement range of 50 to 21,600 U/mL, single-point calibration, 30-day calibration stability, a 90µL sample requirement and 18-month open-bottle stability when stored at 2Þ to 8ÞC.
Beckman Coulter
www.beckmancoulter.com
Keyword: assay, DNase B, streptococcal
